Vir Biotechnology Stock (NASDAQ: VIR) stock price, news, charts, stock research, profile.
You can purchase shares of Vir Biotechnology (NASDAQ:VIR) through any online brokerage.
Other companies in Vir Biotechnology’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), 89bio (NASDAQ:ETNB), Gyre Therapeutics (NASDAQ:GYRE), Syndax Pharmaceuticals (NASDAQ:SNDX) and Replimune Group (NASDAQ:REPL).
Vir Biotechnology has a consensus price target of $30.83.
The stock price for Vir Biotechnology (NASDAQ: VIR) is $9.67 last updated February 20, 2025 at 6:05 PM EST.
There are no upcoming dividends for Vir Biotechnology.
Vir Biotechnology’s Q1 earnings are confirmed for Thursday, May 1, 2025.
There is no upcoming split for Vir Biotechnology.
Vir Biotechnology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.